APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Research

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Research Report 2026

22 December 2025132 pages

Choose your research edition.

Industry ResearchPorcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines include CAHIC, Agrovet, Bioveta, Boehringer Ingelheim, CAVAC, Ceva, DHN, Komipharm and MSD Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (m units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Company

CAHIC

Agrovet

Bioveta

Boehringer Ingelheim

CAVAC

Ceva

DHN

Komipharm

MSD Animal Health

Phibro Animal Health

PULILE

Ringpu Biology

Tecon

WINSUN

ChengDu Tecbond

Sino Pharm

Jinyu Bio-Technology

Qilu Animal

Zoetis

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application

Government Tender

Market Sales

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units) of Manufacturers (2021-2026) Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price (US$/k unit) of Manufacturers (2021-2026) Table 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Product Type & Application Table 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. CAHIC Company Information Table 19. CAHIC Business Overview Table 20. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 21. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 22. CAHIC Recent Developments Table 23. Agrovet Company Information Table 24. Agrovet Business Overview Table 25. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 26. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 27. Agrovet Recent Developments Table 28. Bioveta Company Information Table 29. Bioveta Business Overview Table 30. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 31. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 32. Bioveta Recent Developments Table 33. Boehringer Ingelheim Company Information Table 34. Boehringer Ingelheim Business Overview Table 35. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 36. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 37. Boehringer Ingelheim Recent Developments Table 38. CAVAC Company Information Table 39. CAVAC Business Overview Table 40. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 41. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 42. CAVAC Recent Developments Table 43. Ceva Company Information Table 44. Ceva Business Overview Table 45. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 46. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 47. Ceva Recent Developments Table 48. DHN Company Information Table 49. DHN Business Overview Table 50. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 51. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 52. DHN Recent Developments Table 53. Komipharm Company Information Table 54. Komipharm Business Overview Table 55. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 56. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 57. Komipharm Recent Developments Table 58. MSD Animal Health Company Information Table 59. MSD Animal Health Business Overview Table 60. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 61. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 62. MSD Animal Health Recent Developments Table 63. Phibro Animal Health Company Information Table 64. Phibro Animal Health Business Overview Table 65. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 66. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 67. Phibro Animal Health Recent Developments Table 68. PULILE Company Information Table 69. PULILE Business Overview Table 70. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 71. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 72. PULILE Recent Developments Table 73. Ringpu Biology Company Information Table 74. Ringpu Biology Business Overview Table 75. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 76. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 77. Ringpu Biology Recent Developments Table 78. Tecon Company Information Table 79. Tecon Business Overview Table 80. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 81. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 82. Tecon Recent Developments Table 83. WINSUN Company Information Table 84. WINSUN Business Overview Table 85. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 86. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 87. WINSUN Recent Developments Table 88. ChengDu Tecbond Company Information Table 89. ChengDu Tecbond Business Overview Table 90. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 91. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 92. ChengDu Tecbond Recent Developments Table 93. Sino Pharm Company Information Table 94. Sino Pharm Business Overview Table 95. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 96. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 97. Sino Pharm Recent Developments Table 98. Jinyu Bio-Technology Company Information Table 99. Jinyu Bio-Technology Business Overview Table 100. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 101. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 102. Jinyu Bio-Technology Recent Developments Table 103. Qilu Animal Company Information Table 104. Qilu Animal Business Overview Table 105. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 106. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 107. Qilu Animal Recent Developments Table 108. Zoetis Company Information Table 109. Zoetis Business Overview Table 110. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 111. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 112. Zoetis Recent Developments Table 113. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2026) & (m units) Table 115. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2021-2026) Table 116. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2027-2032) & (m units) Table 117. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2027-2032) Table 118. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2021-2026) Table 120. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2027-2032) Table 122. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 124. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 125. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 129. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 130. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 134. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 135. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 139. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 140. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 144. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 145. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 148. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (m units) Table 149. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2021-2026) Table 150. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2027-2032) Table 151. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2021-2026) Table 154. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2027-2032) Table 155. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2021-2026) & (US$/k unit) Table 156. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2027-2032) & (US$/k unit) Table 157. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 158. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (m units) Table 159. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2021-2026) Table 160. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2027-2032) Table 161. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2021-2026) Table 164. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2027-2032) Table 165. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2021-2026) & (US$/k unit) Table 166. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2027-2032) & (US$/k unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List Table 170. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers List Table 171. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends Table 172. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers Table 173. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Image Figure 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2021-2032) & (m units) Figure 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price (US$/k unit) & (2021-2032) Figure 9. Live Vaccines Product Image Figure 10. Killed Vaccines Product Image Figure 11. Government Tender Product Image Figure 12. Market Sales Product Image Figure 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region in 2025 Figure 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region in 2025 Figure 20. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country in 2025 Figure 21. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2032) Figure 22. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2021-2032) Figure 23. United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country in 2025 Figure 27. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2032) Figure 28. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2021-2032) Figure 29. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country in 2025 Figure 40. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2021-2032) Figure 42. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country in 2025 Figure 51. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2032) Figure 52. South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2021-2032) Figure 53. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country in 2025 Figure 57. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2021-2032) Figure 59. Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2021-2032) Figure 65. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2021-2032) Figure 66. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (US$/k unit) by Type (2021-2032) Figure 67. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2021-2032) Figure 68. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2021-2032) Figure 69. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (US$/k unit) by Application (2021-2032) Figure 70. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Figure 71. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • CAHIC
  • Agrovet
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva
  • DHN
  • Komipharm
  • MSD Animal Health
  • Phibro Animal Health
  • PULILE
  • Ringpu Biology
  • Tecon
  • WINSUN
  • ChengDu Tecbond
  • Sino Pharm
  • Jinyu Bio-Technology
  • Qilu Animal
  • Zoetis

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2021-2032)
  5. 2.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Average Price (2021-2032)
  6. 2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Live Vaccines
  9. 2.3.3 Killed Vaccines
  10. 2.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Government Tender
  13. 2.4.3 Market Sales
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units) of Manufacturers (2021-2026)
  3. 3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Established Date
  9. 3.9 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CAHIC
  2. 4.1.1 CAHIC Company Information
  3. 4.1.2 CAHIC Business Overview
  4. 4.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  6. 4.1.5 CAHIC Recent Developments
  7. 4.2 Agrovet
  8. 4.2.1 Agrovet Company Information
  9. 4.2.2 Agrovet Business Overview
  10. 4.2.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  12. 4.2.5 Agrovet Recent Developments
  13. 4.3 Bioveta
  14. 4.3.1 Bioveta Company Information
  15. 4.3.2 Bioveta Business Overview
  16. 4.3.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  18. 4.3.5 Bioveta Recent Developments
  19. 4.4 Boehringer Ingelheim
  20. 4.4.1 Boehringer Ingelheim Company Information
  21. 4.4.2 Boehringer Ingelheim Business Overview
  22. 4.4.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  24. 4.4.5 Boehringer Ingelheim Recent Developments
  25. 4.5 CAVAC
  26. 4.5.1 CAVAC Company Information
  27. 4.5.2 CAVAC Business Overview
  28. 4.5.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  30. 4.5.5 CAVAC Recent Developments
  31. 4.6 Ceva
  32. 4.6.1 Ceva Company Information
  33. 4.6.2 Ceva Business Overview
  34. 4.6.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  36. 4.6.5 Ceva Recent Developments
  37. 4.7 DHN
  38. 4.7.1 DHN Company Information
  39. 4.7.2 DHN Business Overview
  40. 4.7.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  42. 4.7.5 DHN Recent Developments
  43. 4.8 Komipharm
  44. 4.8.1 Komipharm Company Information
  45. 4.8.2 Komipharm Business Overview
  46. 4.8.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  48. 4.8.5 Komipharm Recent Developments
  49. 4.9 MSD Animal Health
  50. 4.9.1 MSD Animal Health Company Information
  51. 4.9.2 MSD Animal Health Business Overview
  52. 4.9.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  54. 4.9.5 MSD Animal Health Recent Developments
  55. 4.10 Phibro Animal Health
  56. 4.10.1 Phibro Animal Health Company Information
  57. 4.10.2 Phibro Animal Health Business Overview
  58. 4.10.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  60. 4.10.5 Phibro Animal Health Recent Developments
  61. 4.11 PULILE
  62. 4.11.1 PULILE Company Information
  63. 4.11.2 PULILE Business Overview
  64. 4.11.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  66. 4.11.5 PULILE Recent Developments
  67. 4.12 Ringpu Biology
  68. 4.12.1 Ringpu Biology Company Information
  69. 4.12.2 Ringpu Biology Business Overview
  70. 4.12.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  72. 4.12.5 Ringpu Biology Recent Developments
  73. 4.13 Tecon
  74. 4.13.1 Tecon Company Information
  75. 4.13.2 Tecon Business Overview
  76. 4.13.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  78. 4.13.5 Tecon Recent Developments
  79. 4.14 WINSUN
  80. 4.14.1 WINSUN Company Information
  81. 4.14.2 WINSUN Business Overview
  82. 4.14.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  84. 4.14.5 WINSUN Recent Developments
  85. 4.15 ChengDu Tecbond
  86. 4.15.1 ChengDu Tecbond Company Information
  87. 4.15.2 ChengDu Tecbond Business Overview
  88. 4.15.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  90. 4.15.5 ChengDu Tecbond Recent Developments
  91. 4.16 Sino Pharm
  92. 4.16.1 Sino Pharm Company Information
  93. 4.16.2 Sino Pharm Business Overview
  94. 4.16.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  96. 4.16.5 Sino Pharm Recent Developments
  97. 4.17 Jinyu Bio-Technology
  98. 4.17.1 Jinyu Bio-Technology Company Information
  99. 4.17.2 Jinyu Bio-Technology Business Overview
  100. 4.17.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  102. 4.17.5 Jinyu Bio-Technology Recent Developments
  103. 4.18 Qilu Animal
  104. 4.18.1 Qilu Animal Company Information
  105. 4.18.2 Qilu Animal Business Overview
  106. 4.18.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  108. 4.18.5 Qilu Animal Recent Developments
  109. 4.19 Zoetis
  110. 4.19.1 Zoetis Company Information
  111. 4.19.2 Zoetis Business Overview
  112. 4.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  114. 4.19.5 Zoetis Recent Developments
5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Scenario by Region
  1. 5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
  16. 5.5.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  18. 5.5.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
  41. 5.7.1 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  43. 5.7.3 South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032)
  2. 6.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032) & (m units)
  3. 6.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2032)
  5. 6.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032)
  2. 7.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032) & (m units)
  3. 7.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2032)
  5. 7.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Analysis
  2. 8.1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process
  5. 8.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
  8. 8.2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
9 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Analyzing Market Dynamics
  1. 9.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
  2. 9.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers
  3. 9.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges
  4. 9.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst